Raritan, N.J. – December 7, 2010 — iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced that Eurand Pharmaceuticals, Inc. a global specialty pharmaceutical company, has selected iContracts “Universal Contract Manager” (UCM) to effectively manage contracts, improve visibility, control access, and measure performance. Eurand will utilize iContracts UCM as a software service over the web, thus requiring no investment in facilities, hardware, software, or related costs.
Lilly Kritou, Senior Manager in Contract Management for Eurand, stated, “It was important to find a system that would not only be capable of managing our rapidly growing volume of contracts, but also a solution that offers a flexible, secure environment for contract creation, visibility and control. Once Eurand completed a thorough review of alternatives, it was clear that iContracts’ unique approach to managing contracts of all types, as embodied in its revolutionary Universal Contract Manager, was easily the best fit. We look forward to working with iContracts on this critical project which will allow Eurand to systematize contract visibility throughout the enterprise.”
Leigh Powell, Chief Executive Officer of iContracts noted, “We are excited to be working with a truly visionary company in the pharmaceutical and biopharmaceutical industry. Throughout the entire process leading to selection of iContracts Universal Contract Manager, it was clear that Eurand was focused on more than simply addressing today’s issues, but was equally centered on their needs as a fast scaling business well into the future. We are excited to welcome Eurand as yet another new iContracts client and look forward to a long lasting relationship.”
iContracts’ solutions are available as an “on demand” service or as a behind-the-firewall offering and are built on iContracts’ revolutionary BCS platform featuring an advanced data architecture, rich functionality and Simplified Common User Interface (SCUI) enabling users to execute any process after learning just two basic screen formats. This groundbreaking design drastically reduces implementation; training and future upgrade timeframes and costs.
About iContracts
iContract’s goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is generations ahead of other solutions, powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and backed by the most highly evolved data architecture in the industry – built by technologists with considerable and unique experience in building contract management solutions for the Life Sciences and Hospital industry. This deep understanding and straightforward approach shows in everything we do. iContracts comprehensive suite of solutions manages all aspects of a company’s contract management, chargeback, rebate, and government compliance processes. iContracts™ Universal Contract Manager (UCM) is revolutionizing how Life Science companies and other organizations think about the contract management process, transforming it from an unwieldy collection of spreadsheets, custom applications, filing cabinets, and scattered electronic directories to a powerful tool that aligns strategy with execution, while simultaneously insuring greater visibility into commitments and the ability of companies to support growing needs for regulatory reporting and audits. Our solutions are enterprise-class and can be quickly and easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About Eurand Pharmaceuticals
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.
iContracts Media Contact:
Anne Ambrosio
iContracts, Inc.
Tel: 908-393-9550
aambrosio@icontracts.com